OAM
Ostrum Asset Management Portfolio holdings
AUM
$2.13B
This Quarter Return
+1.61%
1 Year Return
+23.57%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.15B
AUM Growth
+$1.15B
(-9.4%)
Cap. Flow
-$86.4M
Cap. Flow
% of AUM
-7.54%
Top 10 Holdings %
Top 10 Hldgs %
16.47%
Holding
663
New
9
Increased
136
Reduced
495
Closed
19
Top Buys
| 1 |
NVIDIA
NVDA
|
$26.9M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$8.61M |
| 3 |
Chipotle Mexican Grill
CMG
|
$2.81M |
| 4 |
Baker Hughes
BKR
|
$2.45M |
| 5 |
Mettler-Toledo International
MTD
|
$2.38M |
Top Sells
| 1 |
T-Mobile US
TMUS
|
$3.98M |
| 2 |
Merck
MRK
|
$3.91M |
| 3 |
GoDaddy
GDDY
|
$3.19M |
| 4 |
Globe Life
GL
|
$2.92M |
| 5 |
Eli Lilly
LLY
|
$2.87M |
Sector Composition
| 1 | Technology | 22.88% |
| 2 | Healthcare | 17.87% |
| 3 | Financials | 10.12% |
| 4 | Consumer Staples | 9.95% |
| 5 | Consumer Discretionary | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Verizon
VZ
$186B
| $6.5M | 0.57% |
157,561
-30,625
| -16% | -$1.26M |
|
27
Quest Diagnostics
DGX
$20.3B
| $6.4M | 0.56% |
46,779
-506
| -1% | -$69.3K |
|
28
Hologic
HOLX
$14.9B
| $6.27M | 0.55% |
84,382
+10,244
| +14% | +$761K |
|
29
Thermo Fisher Scientific
TMO
$186B
| $6.17M | 0.54% |
11,159
-1,093
| -9% | -$604K |
|
30
Elevance Health
ELV
$71.8B
| $6.16M | 0.54% |
11,364
-1,110
| -9% | -$601K |
|
31
Incyte
INCY
$16.5B
| $5.98M | 0.52% |
98,651
+3,522
| +4% | +$214K |
|
32
AutoZone
AZO
$70.2B
| $5.9M | 0.51% |
1,990
+583
| +41% | +$1.73M |
|
33
Intercontinental Exchange
ICE
$101B
| $5.84M | 0.51% |
42,693
-1,608
| -4% | -$220K |
|
34
Take-Two Interactive
TTWO
$43B
| $5.6M | 0.49% |
36,036
+13,550
| +60% | +$2.11M |
|
35
AbbVie
ABBV
$372B
| $5.35M | 0.47% |
31,210
-8,650
| -22% | -$1.48M |
|
36
Cisco
CSCO
$274B
| $5.34M | 0.47% |
112,367
+41,631
| +59% | +$1.98M |
|
37
Regeneron Pharmaceuticals
REGN
$61.5B
| $5.28M | 0.46% |
5,022
+1,563
| +45% | +$1.64M |
|
38
McDonald's
MCD
$224B
| $5.22M | 0.46% |
20,493
-572
| -3% | -$146K |
|
39
Mastercard
MA
$538B
| $5.19M | 0.45% |
11,767
-392
| -3% | -$173K |
|
40
Amgen
AMGN
$155B
| $5.15M | 0.45% |
16,485
-430
| -3% | -$134K |
|
41
Colgate-Palmolive
CL
$67.9B
| $5.11M | 0.45% |
52,669
-15,723
| -23% | -$1.53M |
|
42
Labcorp
LH
$23.1B
| $5.07M | 0.44% |
24,903
-502
| -2% | -$102K |
|
43
Biogen
BIIB
$19.4B
| $5.04M | 0.44% |
21,737
-1,056
| -5% | -$245K |
|
44
Procter & Gamble
PG
$368B
| $4.97M | 0.43% |
30,114
+727
| +2% | +$120K |
|
45
Home Depot
HD
$405B
| $4.82M | 0.42% |
14,002
-1,981
| -12% | -$682K |
|
46
Becton Dickinson
BDX
$55.3B
| $4.81M | 0.42% |
20,560
-945
| -4% | -$221K |
|
|
47
Merck
MRK
$210B
| $4.78M | 0.42% |
38,640
-31,605
| -45% | -$3.91M |
|
48
Pfizer
PFE
$141B
| $4.71M | 0.41% |
168,264
-66,513
| -28% | -$1.86M |
|
49
Salesforce
CRM
$245B
| $4.68M | 0.41% |
18,184
-7,123
| -28% | -$1.83M |
|
50
Adobe
ADBE
$151B
| $4.65M | 0.41% |
8,378
-133
| -2% | -$73.9K |
|